KEAP1 and alkaline phosphatase measurement: Molecular docking showed that dihydrokaempferol can bind to the active site of the Keap1 protein; thus, dihydrokaempferol can be used as an agonist of the Keap1/Nrf2 pathway to reduce the oxidative stress response in AP [84].